BIMEKIZUMAB

UNII:	09495UIM6V
Formula:
Preferred Substance Name:	BIMEKIZUMAB

1418205-77-2
BIMEKIZUMAB [INN]
BIMEKIZUMAB [JAN]
BIMEKIZUMAB [USAN]
BIMEKIZUMAB [WHO-DD]
BIMEKIZUMAB-BKZX
BIMZELX
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A) AND HOMO SAPIENS IL17F (INTERLEUKIN 17F)), HUMANIZED MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A) AND HOMO SAPIENS IL17F (INTERLEUKIN 17F)), HUMANIZED MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN (1-455) (HUMANIZED VH (HOMO SAPIENS IGHV3-7*01 (88.70%) -(IGHD)-IGHJ1*01) (8.8.18) (1-125)-HOMO SAPIENS IGHG1*01 (CH1 (126-223), HINGE (224-238), CH2 (239- 348), CH3 (349-453), CHS (454-455)) (126-455)), (228-214')- DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-13*02 (80.00%) -IGKJ1*01) (6.3.9) (1'-107') - HOMO SAPIENS IGKC*01 (108'-214')) DIMER (234-234'':237-237'')- BISDISULFIDE
UCB4940
UCB-4940

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BIMEKIZUMAB

Synonyms and Mappings

Resources